Oncology Where old pathways to innovative cancer care fall short, a n... Ignoring half the people in the world cannot be good for business.
Views & Analysis The home advantage in cancer care The optimal cancer care pathway for this complex disease outside the hospital.
News Scholar Rock gets first drug approval as FDA okays Isembyld Scholar Rock has won its first product approval, on its second attempt, as the FDA gives a green light to its spinal muscular atrophy drug Isembyld.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
